Compare LYFT Inc (LYFT) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LYFT Inc vs Revvity Inc — how do they compare? LYFT Inc trades at $16.56 (market cap $6.64B), while Revvity Inc trades at $117.23 (market cap $12.91B). The key difference: Revvity Inc is the larger of the two by market cap, and Revvity Inc pays a 0.24% dividend while LYFT Inc pays none. Which is the better fit depends on your goals.
| LYFT | RVTY | |
|---|---|---|
Market Cap | $6.64B | $12.91B |
Sector | Industrials | Technology |
52-Week High | $24.57 | $117.75 |
52-Week Low | $12.65 | $82.26 |
Enterprise Value | $6.11B | $15.23B |
Dividend Yield | — | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lyft trades at $16.42, down 4.87% today, with a bullish technical outlook from moving averages but bearish oscillators. The company reported Q2 2026 revenue growth of 16.1% to a record $5.5 billion in gross bookings, though EPS missed estimates. Strong cash flow generation and expanding global rider base support fundamentals, while valuation ratios like P/E of 2.55 appear attractive relative to historical norms.
Lyft's outlook is mixed: robust revenue growth and cash flow provide upside potential, but earnings misses and competitive pressures from Uber pose risks. The stock offers value with a consensus price target of $19.17, representing 17% upside, though investors face headwinds from rising expenses and market share battles in the ride-hailing sector.
RVTY trades at $116.10, up 0.07% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $1.41, surpassing the $1.21 estimate, and raised its full-year outlook due to robust diagnostics demand. Revenue remains steady around $2.9 billion, with a net income margin of 8.16%. Analyst consensus is a Buy with a $120.50 price target, and recent news highlights product launches like the SuperFlex prenatal system and high-throughput TB testing platform.
The outlook for RVTY is positive, supported by earnings momentum and strategic innovations, but investors face risks from high valuation multiples and competitive pressures in the healthcare sector. The stock's proximity to its consensus target suggests limited near-term upside, requiring careful monitoring of execution against raised guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About LYFT Inc
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
